Get my own profile
Public access
View all13 articles
2 articles
available
not available
Based on funding mandates
Co-authors
- Jean-Charles SoriaAmgen R&DVerified email at amgen.com
- christophe massardUniversité Paris-Saclay, Faculté de Médecine, Drug Development Department (DITEP), Gustave RoussyVerified email at gustaveroussy.fr
- Antoine HollebecqueConsultant, Gustave Roussy Cancer Campus, VillejuifVerified email at gustaveroussy.fr
- Roger SUNRadiation Oncology & Radiomics team, INSERM U1030, Gustave Roussy Cancer Center, ParisVerified email at gustaveroussy.fr
- Stephane ChampiatGustave RoussyVerified email at igr.fr
- Elaine LimkinGustave RoussyVerified email at gustaveroussy.fr
- Charlotte RobertGustave Roussy, VillejuifVerified email at gustaveroussy.fr
- Sylvain ReuzéGE HealthCareVerified email at ge.com
- Antoine SchernbergGustave RoussyVerified email at gustaveroussy.fr
- loriot yGustave RoussyVerified email at gustaveroussy.fr
- Serge KoscielnyGustave RoussyVerified email at gustaveroussy.fr
- Michel DucreuxUniversité Paris-Saclay, Gustave RoussyVerified email at gustaveroussy.fr
- Chargari CyrusProfessor of Radiation Oncology, Pitié Salpêtrière University HospitalVerified email at aphp.fr
- Stefan MichielsOffice Biostatistics & Epidemiology, Gustave Roussy; Oncostat, Univ. Paris Saclay, INSERMVerified email at gustaveroussy.fr
- Frederic CommoGustave RoussyVerified email at gustaveroussy.fr
- François BidaultRadiology department _ BIOMAPSVerified email at gustaveroussy.fr
- Antonin LevyGustave Roussy & Université Paris SaclayVerified email at gustaveroussy.fr
- Evangelia I. ZacharakiComKardia Inc.Verified email at comkardia.com
- Sandrine AspeslaghEarly drug development dept, CTCUVerified email at bordet.be
- Pierre Blanchard, MD PhDGustave RoussyVerified email at gustaveroussy.fr
Follow
Charles Ferté
Resilience - ex: Daiichi Sankyo, Relay Tx, AstraZeneca, Institut Gustave Roussy
Verified email at resilience.care